You have 9 free searches left this month | for more free features.

Asciminib,

Showing 1 - 19 of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Asciminib RMP Study

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Jul 5, 2023

3rd Line Therapy or More to Treat Adult CML- CP in Real World

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Oct 16, 2023

Chronic Myeloid Leukemia Trial (Asciminib)

Available
  • Chronic Myeloid Leukemia
  • (no location specified)
Jan 17, 2023

Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

Completed
  • Chronic Myeloid Leukemia
    • East Hanover, New Jersey
      Novartis
    Nov 20, 2023

    Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • +3 more
    • Augusta, Georgia
    • +1 more
    Jul 14, 2022

    Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

    Not yet recruiting
    • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
    • (no location specified)
    Jun 7, 2022

    Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Trial (Asciminib, Nilotinib)

    Not yet recruiting
    • Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
    • (no location specified)
    Jul 11, 2022

    CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)

    Recruiting
    • CML
    • +3 more
    • Asciminib add-on
    • +3 more
    • Augusta, Georgia
    • +46 more
    Jan 23, 2023

    Myeloid Leukemia, Philadelphia Positive Trial in Worldwide (Asciminib Pediatric formulation group, Asciminib Adult formulation

    Recruiting
    • Myeloid Leukemia, Philadelphia Positive
    • Asciminib Pediatric formulation group
    • Asciminib Adult formulation group
    • Boston, Massachusetts
    • +24 more
    Jan 17, 2023

    Leukemia, Chronic Myelogenous Trial in China (asciminib, best available treatment)

    Recruiting
    • Leukemia, Chronic Myelogenous
    • Chongqing City, Chongqing, China
    • +23 more
    Jan 18, 2023

    Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia
    • Detroit, Michigan
    • +1 more
    May 3, 2022

    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)

    Recruiting
    • Chronic Myelogenous Leukemia
    • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
    • Asciminib single agent
    • +5 more
    • Ann Arbor, Michigan
    • +49 more
    Jan 26, 2023

    Renal Impairment Trial in Sofia, Berlin (Asciminib)

    Completed
    • Renal Impairment
    • Sofia, Bulgaria
    • +1 more
    Oct 7, 2021

    Chronic Myelogenous Leukemia Trial in Worldwide (ABL001 40mg BID, ABL001 80mg QD, ABL001 200mg QD)

    Recruiting
    • Chronic Myelogenous Leukemia
    • ABL001 40mg BID
    • +2 more
    • Caba, Buenos Aires, Argentina
    • +53 more
    Jan 27, 2023

    Chronic Myelogenous Leukemia - Chronic Phase Trial (asciminib)

    Recruiting
    • Chronic Myelogenous Leukemia - Chronic Phase
    • Birmingham, Alabama
    • +25 more
    Jan 10, 2023

    Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Trial in Houston (Asciminib)

    Recruiting
    • Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 1, 2022

    Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Trial in Worldwide (Imatinib, Nilotinib, Bosutinib)

    Recruiting
    • Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
    • Longmont, Colorado
    • +128 more
    Aug 1, 2022

    Special Drug Use-results Surveillance of Scemblix Tablets

    Recruiting
    • Chronic Myeloid Leukemia
    • Asciminib
    • Toyohashi, Aichi, Japan
    • +24 more
    Aug 10, 2022

    Chronic Myelogenous Leukemia Trial in Worldwide (Asciminib, Bosutinib)

    Active, not recruiting
    • Chronic Myelogenous Leukemia
    • Chicago, Illinois
    • +87 more
    Jan 20, 2023